跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,894 条关于
“p38 MAPK”
全部
1,894
临床试验
1,334
药物
264
机构
13
资讯
283
5个月前
Poolbeg Pharma Advances POLB 001 Cancer Therapy with FDA Approval and Canadian Patent
10个月前
Poolbeg Pharma Secures European Patent for POLB 001 Targeting Severe Influenza and Cancer Immunotherapy Side Effects
去年
Poolbeg Pharma Secures £4.1 Million Fundraising to Advance Clinical Programs in Oncology and Obesity
去年
CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies
去年
TREM2 Emerges as Dual Regulator of Lipid Metabolism and Immune Response in MASH
3个月前
GLP-1 Receptor Agonists Linked to Fewer Diabetic Foot Ulcers but Higher Charcot Risk Than DPP-4 Inhibitors
8个月前
Derazantinib Enhances Gemcitabine Efficacy in Pancreatic Cancer by Suppressing NF-κB and MAPK Pathways
去年
PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors
去年
Immuneering Partners with Lilly for Phase 2 NSCLC Combination Trial Testing Dual MAPK Pathway Blockade
2年前
Nested Therapeutics' NST-628: A Novel Pan-RAF–MEK Molecular Glue for MAPK Pathway Inhibition
第 1 页,共 29 页
上一页
下一页